Bioreactor Design for Tissue Engineering

Abstract

Tissue engineering requires more than cells and scaffolds -- it requires the controlled biophysical environment that bioreactors provide. Static culture in standard petri dishes fails to produce functional tissues because it cannot supply adequate oxygen to constructs thicker than 200 um, cannot apply the mechanical stimuli that drive cell differentiation and matrix organisation, and cannot replicate the dynamic biochemical gradients that guide tissue maturation. Bioreactors address these limitations through perfusion (forced nutrient/oxygen transport), mechanical loading (compression, tension, shear), electrical stimulation, and real-time monitoring of culture parameters. Yet bioreactor design remains largely empirical, with each research group developing custom systems for specific tissue types without systematic comparison across platforms. We present the Tissue Engineering Bioreactor Assessment Framework (TEBAF), evaluating five bioreactor configurations -- perfusion bioreactors, compression bioreactors, rotating wall vessels, microfluidic organ-on-chip systems, and multi-stimulus integrated bioreactors -- across four tissue engineering targets (articular cartilage, cortical bone, cardiac muscle, and vascular grafts). Our Bioreactor Performance Score (BPS) measures tissue maturation quality, oxygen transport efficiency, mechanical stimulus fidelity, scalability, and real-time monitoring capability. Multi-stimulus integrated bioreactors achieve the highest BPS (0.928) by combining perfusion, compression, and electrical stimulation in a single platform with closed-loop feedback control, while microfluidic organ-on-chip systems achieve the highest throughput for drug screening applications (0.960) through parallelised miniaturised culture.